FDA inspection
Novartis Pharma Schweizerhalle Ag: FDA inspection ending Aug 25, 2022
FDA inspection 1180967 · No Action Indicated (NAI) · Pratteln
Key facts
| Inspection ID | 1180967 |
|---|---|
| Firm | Novartis Pharma Schweizerhalle Ag |
| FEI number | 3002865753 |
| Address | Rothausstrasse 61 |
| City | Pratteln |
| Country | Switzerland |
| Fiscal year | 2022 |
| Inspection end date | Aug 25, 2022 |
| Classification | No Action Indicated (NAI) |
| Project area | Drug Quality Assurance |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- No Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 10–99 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data